Globally, diabetes represents a considerable burden on healthcare systems, with an age-standardized total prevalence of 6.1% in 2021. The burden of diabetes ...
Higher all-cause and cardiovascular mortality predicted with concurrent hypertension and type 2 diabetes. (HealthDay News) — Adults with concurrent hypertension and type 2 diabetes (T2D) have high ...
May 27, 2025-- U.S. adults with both hypertension and Type 2 diabetes (T2D) face a significantly higher risk of all-cause and cardiovascular mortality compared to those with only one of these ...
Both the cause and a potential cure for the most common identifiable and specifically treatable cause of hypertension – aldosterone-producing adenomas (APAs) – have been revealed by researchers from ...
Figure 3. ACE inhibitors and ARBs have different sites of action within the RAS pathway. The solid arrows indicate activation, and the dashed arrows indicate inhibition. ACE = angiotensin-converting ...
(HealthDay News) — Adults with concurrent hypertension and type 2 diabetes (T2D) have high mortality risk compared with those who have neither condition or only one, according to a study published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results